Henry DH, Weycker D, Bensink M, Gawade P, Belani R. Optimal timing for pegfilgrastim administration in Japanese breast cancer patients receiving intermediate-risk chemotherapies: response to study by Hayama et al. Int J Clin Pharm. 2019 Apr 5. doi: 10.1007/s11096-018-0752-3. [Epub ahead of print] - PAI - Policy Analysis Inc.

Henry DH, Weycker D, Bensink M, Gawade P, Belani R. Optimal timing for pegfilgrastim administration in Japanese breast cancer patients receiving intermediate-risk chemotherapies: response to study by Hayama et al. Int J Clin Pharm. 2019 Apr 5. doi: 10.1007/s11096-018-0752-3. [Epub ahead of print] - PAI - Policy Analysis Inc.